BioWorld

Oct. 13, 2008

View Archived Issues

Stock Winners and Losers For The Week

Public Financing of Biotechnology: September 2008

Other Financings of Public Biotechnology Companies: September 2008

Venture Capital and Other Investments in Private Biotechnology Companies: September 2008

Milestone Payments from Corporate Partners: September 2008

Money Raised in 2008

More Biotech Bankruptcies Might Not Be All Bad

A recent analysis by Jefferies & Co. Inc. of more than 300 loss-making biotechs showed that about 43 percent of the companies are operating with less than a year of cash. (BioWorld Financial Watch) Read More

Money Raised Year to Date

Stock Indexes

BioWorld Stock Report For Public Biotechnology Companies

Today's news in brief

BioWorld

BioWorld briefs for April 17, 2026.

Man holding raised arm with illustrated overlay of nerves

Biohaven reports details on discovery of BHV-2100

BioWorld Science

Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...

New GABA(B) receptor PAMs revealed in Addex Pharma patents

BioWorld Science

Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...

Elderly woman holding illustration of brain with missing puzzle piece

Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

BioWorld

The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...

Novel caspase-2 inhibitor shows in vivo neuroprotective effects

BioWorld Science

Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...